Doseology Sciences Inc. has announced that its shares have been uplisted to the OTCQB Venture Market in the United States under the ticker DOSEF, marking a step toward expanding access for U.S. investors. The company continues to trade on the Canadian Securities Exchange under MOOD and on the Frankfurt Stock Exchange as VU70.
The OTCQB listing is designed to improve visibility, transparency, and accessibility for U.S. investors interested in the rapidly emerging oral stimulant pouch category. By trading on OTCQB, companies must meet higher financial reporting standards and remain current with disclosures, which can increase investor confidence and liquidity.
Doseology is positioning itself as an early public company focused on pouch-based stimulant delivery formats, a segment gaining momentum as consumers seek portable, discreet alternatives to traditional products such as energy drinks or other stimulant formats. Oral pouch technologies allow for controlled-dose delivery in a smokeless, convenient form factor.
The company is pursuing a platform strategy that combines product development, brand building, and digital distribution. Through its growing portfolio—including the recently acquired Feed That Brain brand—Doseology aims to develop a scalable ecosystem of stimulant products designed for modern lifestyles and on-the-go use.
Industry interest in oral pouch formats has increased significantly in recent years, with large consumer and tobacco companies investing heavily in modern oral products as demand shifts toward smoke-free delivery systems. Doseology believes similar innovation could expand into the broader stimulant and energy market.
The OTCQB uplisting reflects the company’s broader strategy to strengthen its capital markets presence while advancing commercialization of its oral stimulant pouch technologies in North America.
